Palisade Bio Inc
NASDAQ:PALI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Palisade Bio Inc
NASDAQ:PALI
|
US |
|
O
|
Orezone Gold Corp
XBER:OEX
|
CA |
|
B
|
Banca Mediolanum SpA
OTC:BNMDF
|
IT |
|
A
|
Amcor PLC
F:485
|
UK |
|
Aptose Biosciences Inc
F:LTI0
|
CA |
|
B
|
Berry Global Group Inc
SWB:BP0
|
US |
|
S
|
Seabridge Gold Inc
F:SRM
|
CA |
|
O
|
Occidental Petroleum Corp
XBER:OPC
|
US |
|
Berry Global Group Inc
NYSE:BERY
|
US |
|
Perdoceo Education Corp
NASDAQ:PRDO
|
US |
|
S
|
Srinanaporn Marketing PCL
SET:SNNP
|
TH |
|
Fairfax Financial Holdings Ltd
TSX:FFH
|
CA |
|
I
|
IONOS Group SE
F:IOS
|
DE |
|
L
|
Leonardo SpA
DUS:FMNB
|
IT |
|
A
|
Amerisafe Inc
F:A3I
|
US |
Wall St Price Targets
PALI Price Targets Summary
Palisade Bio Inc
According to Wall Street analysts, the average 1-year price target for
PALI is 10.88 USD with a low forecast of 5.05 USD and a high forecast of 26.25 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is PALI's stock price target?
Price Target
10.88
USD
According to Wall Street analysts, the average 1-year price target for
PALI is 10.88 USD with a low forecast of 5.05 USD and a high forecast of 26.25 USD.